CK Life Sciences International (Holdings), Inc.
0775.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
$-0.34
163.8% downside
Current Fair Value
163.8% downsideOvervalued by 163.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | - |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | -8.73% |
|---|---|
| Return on Assets | -2.83% |
| Return on Invested Capital | -1.37% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | 1.73 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About CK Life Sciences International (Holdings), Inc.
1,920 employees
CEO: Ying Choi Yu CK Life Sciences International (Holdings), Inc. operates as an investment company, which engages in the business of research and development, manufacturing, commercialization, marketing and selling of products and assets in nutraceutical...